FDA orphan drug designation: treatment of systemic sclerosis
All entries for: a subsidiary of Bristol Myers Squibb
December 19, 2025
a subsidiary of Bristol Myers Squibb
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of systemic sclerosis